| Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection L Montefusco, M Ben Nasr, F D’Addio, C Loretelli, A Rossi, I Pastore, ... Nature Metabolism 3 (6), 774-785, 2021 | 341 | 2021 |
| Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and COVID-19: a multicenter, case-control … SB Solerte, F D’Addio, R Trevisan, E Lovati, A Rossi, I Pastore, ... Diabetes care 43 (12), 2999-3006, 2020 | 266 | 2020 |
| Anti-diabetic drugs and weight loss in patients with type 2 diabetes E Lazzaroni, MB Nasr, C Loretelli, I Pastore, L Plebani, ME Lunati, ... Pharmacological Research 171, 105782, 2021 | 106 | 2021 |
| The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists G Bendotti, L Montefusco, ME Lunati, V Usuelli, I Pastore, E Lazzaroni, ... Pharmacological Research 182, 106320, 2022 | 96 | 2022 |
| Postpartum glucose intolerance: an updated overview I Pastore, E Chiefari, R Vero, A Brunetti Endocrine 59 (3), 481-494, 2018 | 61 | 2018 |
| PD-1 blockade counteracts post–COVID-19 immune abnormalities and stimulates the anti–SARS-CoV-2 immune response C Loretelli, A Abdelsalam, F D’Addio, MB Nasr, E Assi, V Usuelli, ... JCI insight 6 (24), 2021 | 54 | 2021 |
| Impact of seasonality on gestational diabetes mellitus E Chiefari, I Pastore, L Puccio, P Caroleo, R Oliverio, A Vero, D P Foti, ... Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2017 | 41 | 2017 |
| Anti-inflammatory effects of diet and caloric restriction in metabolic syndrome L Montefusco, F D’addio, C Loretelli, M Ben Nasr, M Garziano, A Rossi, ... Journal of Endocrinological Investigation, 1-9, 2021 | 38 | 2021 |
| The impact of diabetes mellitus on cardiovascular risk onset in children and adolescents I Pastore, AM Bolla, L Montefusco, ME Lunati, A Rossi, E Assi, GV Zuccotti, ... International journal of molecular sciences 21 (14), 4928, 2020 | 37 | 2020 |
| Indirect and direct effects of SARS-CoV-2 on human pancreatic islets M Ben Nasr, F D’Addio, L Montefusco, V Usuelli, C Loretelli, A Rossi, ... Diabetes 71 (7), 1579-1590, 2022 | 35 | 2022 |
| The correct renal function evaluation in patients with thyroid dysfunction M Simeoni, A Cerantonio, I Pastore, R Liguori, M Greco, D Foti, E Gulletta, ... Journal of Endocrinological Investigation 39, 495-507, 2016 | 35 | 2016 |
| SGLT2-inhibitors are effective and safe in the elderly: The SOLD study ME Lunati, V Cimino, A Gandolfi, M Trevisan, L Montefusco, I Pastore, ... Pharmacological Research 183, 106396, 2022 | 30 | 2022 |
| The IL-8-CXCR1/2 axis contributes to diabetic kidney disease C Loretelli, F Rocchio, F D'Addio, MB Nasr, E Castillo-Leon, S Dellepiane, ... Metabolism 121, 154804, 2021 | 26 | 2021 |
| Immunogenicity and safety of SARS-CoV-2 mRNA vaccines in a cohort of patients with type 1 diabetes F D’Addio, G Sabiu, V Usuelli, E Assi, A Abdelsalam, A Maestroni, ... Diabetes 71 (8), 1800-1806, 2022 | 25 | 2022 |
| HMGA1 is a novel transcriptional regulator of the FoxO1 gene B Arcidiacono, E Chiefari, S Messineo, FL Bilotta, I Pastore, ... Endocrine 60, 56-64, 2018 | 25 | 2018 |
| miR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy V Usuelli, MB Nasr, F D’Addio, K Liu, A Vergani, B El Essawy, J Yang, ... American Journal of Transplantation 21 (10), 3280-3295, 2021 | 24 | 2021 |
| Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns E Assi, F D'Addio, C Mandò, A Maestroni, C Loretelli, MB Nasr, V Usuelli, ... BMJ Open Diabetes Research and Care 8 (2), e001586, 2020 | 16 | 2020 |
| Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease A Petrazzuolo, G Sabiu, E Assi, A Maestroni, I Pastore, ME Lunati, ... Pharmacological Research 190, 106710, 2023 | 15 | 2023 |
| Continuous glucose monitoring in patients with type 2 diabetes on hemodialysis M Gallieni, C De Salvo, ME Lunati, A Rossi, F D’Addio, I Pastore, G Sabiu, ... Acta Diabetologica 58, 975-981, 2021 | 15 | 2021 |
| Dapagliflozin acutely improves kidney function in type 2 diabetes mellitus. The PRECARE study E Lazzaroni, ME Lunati, L Montefusco, I Pastore, E Chebat, V Cimino, ... Pharmacological Research 183, 106374, 2022 | 12 | 2022 |
